Transgenic Group (2342) Earnings: Operating Income Up 261.2% YoY to 163 Million Yen, Net Income Jumps 404.6%

Transgenic Group (2342) released its latest financial results, reporting net sales of 3,659 million yen, a 14.4% increase compared to the same period of the previous year. Operating income surged 261.2% YoY to 163 million yen, while ordinary income grew 154.3% to 156 million yen. Profit attributable to owners of the parent significantly increased by 404.6% YoY to 136 million yen, resulting in earnings per share (EPS) of 8.17 yen.

From a financial perspective, the company maintains a stable capital adequacy ratio of 50.1%, reflecting a solid financial foundation. Interest-bearing debt stands at 2.61 billion yen, alongside retained earnings of 0.99 billion yen. This robust earnings growth across all profit tiers highlights the company's enhanced profitability and operational performance.